Target intelligence / Profile preview

Optic atrophy 1 pre-mRNA (pre-mRNA transcript of the Optic atrophy 1 gene) (OPA1 pre-mRNA)

Target
OPA1 pre-mRNA
Molecular classification
Other (RNA precursor; not an enzyme, receptor, transporter, etc.)
01

Overview

The OPA1 pre-mRNA is the unspliced transcript of the **Optic atrophy 1 gene (OPA1)**, encoding the mitochondrial dynamin-like GTPase critical for mitochondrial inner membrane fusion, cristae architecture, and apoptotic regulation. The OPA1 gene undergoes complex alternative splicing, producing eight different mRNA isoforms, which give rise to long and short protein forms essential for mitochondrial function. Pathogenic variants in the gene, including those affecting splicing of the pre-mRNA, can lead to dominant optic atrophy and syndromic forms (DOA+), often through haploinsufficiency or dominant-negative mechanisms[6][7][8]. OPA1 pre-mRNA itself is not a direct drug target but is of high research interest for its role in disease mechanisms and potential as a biomarker.

Other names
OPA1 pre-mRNAOPA1 precursor RNAOPA1 transcript before splicing
02

Mechanism of action

Modulation of splicing could change OPA1 isoform ratio, potentially affecting disease outcomes

03

Biological functions

Precursor to OPA1 proteintemplate for alternative splicing to generate different OPA1 isoforms
04

Disease associations

Neurodegenerative disease (through involvement in dominant optic atrophy if mutations or mis-splicing occur)
05

Safety considerations

Off-target effects of potential splicing modulatorsdisruption of mitochondrial function if OPA1 splicing is altered
06

Interacting drugs

none specific to pre-mRNA (some research into splicing modulators, but not clinically established)
07

Biomarkers

Mutations or aberrant splicing in OPA1 pre-mRNA can act as genetic biomarkers for optic atrophy and related syndromes

Beyond the preview

Go deeper on Optic atrophy 1 pre-mRNA (pre-mRNA transcript of the Optic atrophy 1 gene) (OPA1 pre-mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optic atrophy 1 pre-mRNA (pre-mRNA transcript of the Optic atrophy 1 gene) (OPA1 pre-mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call